Germany vs Vanuatu: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Germany
74.0%
in 2025
Vanuatu
76.0%
in 2025
Germany rank
131st
Vanuatu rank
128th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Germany
- Vanuatu
How they compare
Vanuatu currently reports 76.0% against 74.0% in Germany, a difference of 2.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Germany ahead.
Germany ranks 131st and Vanuatu ranks 128th of 194 countries.
Germany has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Germany | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 76.0% | 0.0% | 76.0% | Germany |
| 2010s | 83.2% | 0.0% | 83.2% | Germany |
| 2020s | 76.5% | 49.0% | 27.5% | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Germany or Vanuatu?
- Vanuatu, at 76.0% against 74.0% in Germany as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Germany and Vanuatu?
- 2.0%, with Vanuatu ahead.
- How many years of comparable data are there for Germany and Vanuatu?
- 18 years are reported by both, from 2008 to 2025.
- How do Germany and Vanuatu rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Germany ranks 131st and Vanuatu ranks 128th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.